Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 71 Records) |
| Query Trace: Lung Neoplasms and Cdkn2a[original query] |
|---|
| Impact of Tumor Suppressor Gene Co-Mutations on Differential Response to EGFR TKI Therapy in EGFR L858R and Exon 19 Deletion Lung Cancer. Clinical lung cancer 2021 Oct . Hellyer Jessica A, White Maya N, Gardner Rebecca M, Cunanan Kristen, Padda Sukhmani K, Das Millie, Ramchandran Kavitha, Neal Joel W, Wakelee Heather |
| RET fusions as primary oncogenic drivers and secondary acquired resistance to EGFR tyrosine kinase inhibitors in patients with non-small-cell lung cancer. Journal of translational medicine 2022 Sep 20 (1): 390. Wang Chunyue, Zhang Zhenlong, Sun Yulan, Wang Song, Wu Mengmeng, Ou Qiuxiang, Xu Yang, Chen Zhiming, Shao Yang, Liu Hong, Hou Peife |
| Clinical outcomes and immune phenotypes associated with STK11 co-occurring mutations in non-small cell lung cancer. Journal of thoracic disease 2022 7 14 (6): 1772-1783. Malhotra Jyoti, Ryan Brid, Patel Malini, Chan Nancy, Guo Yanxiang, Aisner Joseph, Jabbour Salma K, Pine Shar |
| Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA. OncoTargets and therapy 2022 5 15 571-584. Li Jie, Chen Siwen, Xue Hui, Wang Haoyi, Huang Tianwei, Xie Hongya, He Jiang, Ke Cai, Yu Zhaonan, Ni B |
| Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing. BMC cancer 2022 May 22 (1): 580. Yang Hainan, Wen Lei, Pan Yingying, Shan Changguo, Hong Weiping, Wang Hui, Zhou Cheng, Cai Linbo, Zhou Caic |
| Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases. The oncologist 2022 May . Huang Richard S P, Harries Lukas, Decker Brennan, Hiemenz Matthew C, Murugesan Karthikeyan, Creeden James, Tolba Khaled, Stabile Laura P, Ramkissoon Shakti H, Burns Timothy F, Ross Jeffrey |
| The prevalence and real-world therapeutic analysis of Chinese patients with KRAS-Mutant Non-Small Cell lung cancer. Cancer medicine 2022 4 11 (19): 3581-3592. Chen Hanxiao, Huang Dingzhi, Lin Gen, Yang Xue, Zhuo Minglei, Chi Yujia, Zhai Xiaoyu, Jia Bo, Wang Jingjing, Wang Yuyan, Li Jianjie, An Tongtong, Wu Meina, Wang Ziping, Zhao J |
| Next-generation Sequencing Reveals Age-dependent Genetic Underpinnings in Lung adenocarcinoma. Journal of Cancer 2022 4 13 (5): 1565-1572. Wu Xiaonan, Zhao Jun, Yang Ling, Nie Xin, Wang Zheng, Zhang Ping, Li Chao, Hu Xueqing, Tang Min, Yi Yuting, Du Xinhua, Xia Xuefeng, Guan Yanfang, Yu Zicheng, Gu Wenguang, Quan Xiangming, Li Lin, Shi Ho |
| Construction and Validation of Early Warning Model of Lung Cancer Based on Machine Learning: A Retrospective Study. Technology in cancer research & treatment 2022 11 21 15330338221136724. Ye Siyu, Pan Jiongwei, Ye Zaiting, Cao Zhuo, Cai Xiaoping, Zheng Hao, Ye Ho |
| Impact of Transcript (p16/p14ARF) Alteration on Cancer Risk in CDKN2A Germline Pathogenic Variant Carriers. JNCI cancer spectrum 2022 10 6 (6): . Sargen Michael R, Helgadottir Hildur, Yang Xiaohong R, Harland Mark, Hatton Jessica N, Jones Kristine, Hicks Belynda D, Hutchinson Amy, Curry Michael, Tucker Margaret A, Goldstein Alisa M, Pfeiffer Ruth |
| Computational Biological Modeling Identifies PD-(L)1 Immunotherapy Sensitivity Among Molecular Subgroups of KRAS-Mutated Non-Small-Cell Lung Cancer. JCO precision oncology 2022 1 5 153-162. Padda Sukhmani K, Aredo Jacqueline V, Vali Shireen, Singh Neeraj K, Vasista Sumanth M, Kumar Ansu, Neal Joel W, Abbasi Taher, Wakelee Heather |
| Palbociclib in Patients With Non-Small-Cell Lung Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study. JCO precision oncology 2022 1 4 757-766. Ahn Eugene R, Mangat Pam K, Garrett-Mayer Elizabeth, Halabi Susan, Dib Elie G, Haggstrom Daniel E, Alguire Kathryn B, Calfa Carmen J, Cannon Timothy L, Crilley Pamela A, Gaba Anu G, Marr Alissa S, Sangal Ashish, Thota Ramya, Antonelli Kaitlyn R, Islam Samiha, Rygiel Andrew L, Bruinooge Suanna S, Schilsky Richard |
| Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer Patients. Cancers 2022 May 14 (10): . Ulivi Paola, Urbini Milena, Petracci Elisabetta, Canale Matteo, Dubini Alessandra, Bartolini Daniela, Calistri Daniele, Cravero Paola, Fonzi Eugenio, Martinelli Giovanni, Priano Ilaria, Andrikou Kalliopi, Bronte Giuseppe, Crinò Lucio, Delmonte Ange |
| Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis. Nature communications 2023 8 14 (1): 4980. Anna Skakodub, Henry Walch, Kathryn R Tringale, Jordan Eichholz, Brandon S Imber, Harish N Vasudevan, Bob T Li, Nelson S Moss, Kenny Kwok Hei Yu, Boris A Mueller, Simon Powell, Pedram Razavi, Helena A Yu, Jorge S Reis-Filho, Daniel Gomez, Nikolaus Schultz, Luke R G Pi |
| Impact of concurrent genomic alterations on clinical outcomes in patients with ALK-rearranged non-small cell lung cancer. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2023 8 . Luis Lara-Mejía, Andrés F Cardona, Luis Mas, Claudio Martín, Suraj Samtani, Luis Corrales, Graciela Cruz-Rico, Jordi Remon, Marco Galvez-Nino, Rossana Ruiz, Eduardo Rios-Garcia, Fernanda Tejada, Natalia Lozano-Vazquez, Rafael Rosell, Oscar Arrie |
| TP53 Exon 5 Mutation Indicates Poor Progression-Free Survival for Patients with Stage IV NSCLC. Frontiers in bioscience (Landmark edition) 2023 8 28 (7): 147. Huijing Feng, Huiru Xu, Xiuhuan Shi, Guobin Ding, Cihui Yan, Linhan Li, Zuoyi Jian, Xuejing Yang, Hongxia Guo, Feng Li, Junping Zhang, Xiubao R |
| Coexisting Genomic Alterations in Risk Stratification of KRASG12C-Mutated Non-Small Cell Lung Cancer. Cancer discovery 2023 7 13 (7): 1513-1515. Sarina Z W Heng, Regina Hoo, Daniel S W T |
| Genomic characterisation of de novo EGFR copy number gain and its impact on the efficacy of first-line EGFR-tyrosine kinase inhibitors for EGFR mutated non-small cell lung cancer. European journal of cancer (Oxford, England : 1990) 2023 5 188 81-89. Yiquan Xu, Jingjing Yan, Chengzhi Zhou, Lin Wu, Haibo Wang, Jun Zhao, Maolin Zhou, Jingyi Wang, Xinlong Zheng, Longfeng Zhang, Kan Jiang, Xiaobin Zheng, Qian Miao, Shiwen Wu, Zihua Zou, Rong Lian, Yuange He, Rongrong Chen, Shanshan Yang, Yujing Li, Sihui Chen, Gen L |
| Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer. Journal of neuro-oncology 2023 12 . Qian Miao, Xinlong Zheng, Lifeng Li, Xiaobin Zheng, Longfeng Zhang, Kan Jiang, Shiwen Wu, Haibo Wang, Biao Wu, Yiquan Xu, Qiaofeng Zhong, Zihua Zou, Qiuyu Zhang, Shanshan Yang, Yujing Li, Gen L |
| Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases. Journal of neuro-oncology 2023 10 . Kaixuan Bai, Xin Chen, Xuejiao Qi, Yu Zhang, Yueli Zou, Jian Li, Lili Yu, Yuanyuan Li, Jiajia Jiang, Yi Yang, Yajing Liu, Shuanghao Feng, Hui |
| Characterization of driver mutations in Chinese non-small cell lung cancer patients using a novel targeted sequencing panel. Journal of thoracic disease 2023 1 14 (12): 4669-4684. Zhao Jing, Wu Yang, Chen Min-Jiang, Xu Yan, Zhong Wei, Wang Meng-Zh |
| Cerebrospinal fluid-derived circulating tumor DNA is more comprehensive than plasma in NSCLC patients with leptomeningeal metastases regardless of extracranial evolution. Heliyon 2023 1 8 (12): e12374. Yang Hainan, Wen Lei, Zhao Chao, Chen Jianing, Zhou Zhaoming, Zhou Cheng, Cai Linbo, Zhou Caic |
| Clinical Utility of Circulating Tumor DNA for Detecting Lung Cancer Mutations by Targeted Next-Generation Sequencing With Insufficient Tumor Samples. Journal of clinical laboratory analysis 2024 9 e25099. Yi Sun, Xu Zhang, Xinhua Yang, Jiangjun |
| Lung-MAP Next Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 8 . David Kozono, Xing Hua, Michael C Wu, Khaled A Tolba, Saiama N Waqar, Konstantin H Dragnev, Haiying Cheng, Fred R Hirsch, Philip C Mack, Jhanelle E Gray, Karen Kelly, Hossein Borghaei, Roy S Herbst, David R Gandara, Mary W Redm |
| Prevalence of Potentially Pathogenic Germline Variants Among Adult Patients in the Philippines With Solid Malignancies Who Underwent Tumor Genomic Profiling. JCO global oncology 2024 6 10 e2400019. Paula Isabel Franco, Jose Jasper Andal, Daphne Chua Ang, Frances Victoria Q |
| Different genetic profiles contribute to worse overall survival in patients with leptomeningeal metastases of non-small-cell lung cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 5 . Xusheng Tang, Xiaojuan Hu, Lin Yuan, Hainan Yang, Yunfen Luo, Da Liu, Qingjun Hu, Changguo Shan, Tao Lin, Linbo Cai, Zhaoming Zhou, Xin Jin, Ming Lei, Weiping Ho |
| Differential expression of DMD transcripts as a novel prognostic biomarker in histologically diverse mesotheliomas. Translational lung cancer research 2024 5 13 (4): 733-748. Nancy Alnassar, Jonathan M J Derry, Giuseppe Luigi Banna, Dariusz C Gorec |
| Prevalence and Associations of Co-occurrence of NFE2L2 Mutations and Chromosome 3q26 Amplification in Lung Cancer. Global medical genetics 2024 4 11 (2): 150-158. Jinfeng Liu, Sijie Liu, Dan Li, Hongbin Li, Fan Zha |
| Efficacy of immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma and predictive potential of mutated TP53. Lung cancer (Amsterdam, Netherlands) 2024 12 199 108068. Mingying Wu, Na Zhou, Mei Guan, Yingyi Wang, Yuzhou Wa |
| Intrathecal pemetrexed improves survival outcomes in previously treated EGFR-mutant advanced non-small-cell lung cancer with leptomeningeal metastases. Heliyon 2025 1 10 (24): e40703. Liqun Li, Zhe Huang, Yangqian Chen, Hongzhi Ma, Xiaoquan Chen, Huan Yan, Haoyue Qin, Yuda Zhang, Xing Zhang, Wenjuan Jiang, Zhan Wang, Lin Zhang, Fanxu Zeng, Zhiguo Zhou, Xingxiang Pu, Nong Yang, Liang Zeng, Yongchang Zha |
- Page last reviewed:Feb 1, 2024
- Content source: